MedTrace Logo

Integrating Halotherapy Into Preseason Training Improves Respiratory and Aerobic Performance in Elite Female Soccer Players

NCT07406386 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2026-02-12

No results posted yet for this study

Summary

This randomized controlled trial aimed to investigate the effects of a 12-week halotherapy intervention on respiratory muscle strength, pulmonary function, aerobic capacity, and intermittent running performance in elite female soccer players. Participants were randomly assigned to either a halotherapy group or a control group. Both groups followed the same preseason soccer training program, while the halotherapy group additionally received regular halotherapy sessions. Pre- and post-intervention assessments included spirometric measurements, respiratory muscle strength, estimated VO₂max, and Yo-Yo Intermittent Recovery Test Level 1 performance.

Conditions

  • Aerobic Performance
  • Respiratory Function
  • Athletic Performance
  • Respiratory Muscle Strength
  • Elite Female Athletes
  • Halotherapy

Interventions

OTHER

Halotherapy Group

Participants followed the standard preseason soccer training program and additionally received halotherapy. Halotherapy sessions were conducted in a controlled halochamber using a dry salt aerosol generator. Sessions lasted 45 minutes and were performed three times per week for 12 weeks. Aerosol concentration was maintained at approximately 20 mg/m³ with particle size \<5 microns. Environmental conditions were controlled (temperature 20-24°C, humidity 40-60%).

OTHER

Control

Participants followed the same standard preseason soccer training program without halotherapy.

Sponsors & Collaborators

  • Gümüşhane Universıty

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-05
Primary Completion
2022-07-15
Completion
2022-07-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07406386 on ClinicalTrials.gov